Skip to main content
. Author manuscript; available in PMC: 2013 Dec 22.
Published in final edited form as: Genesis. 2011 Dec 27;50(3):10.1002/dvg.20819. doi: 10.1002/dvg.20819

Table 1.

Survival and observed transgene expression efficiencies from injected DNA

Construct Injected Amount
(pg)
Injected
Embryos
Scoreda Survivalb
(%)
Correct
Expressors
Partialc Ectopib GFP- Correct
Expressors
(%)
Pax6 BAC 20 216 197 91% 127 37 9 24 64
Pax6 BAC 40 151 87 58% 49 5 2 31 56
Pax6 BAC 80 114 46 40% 18 6 3 19 39
Xath5 BAC 20 91 76 84% 43 25 1 7 57
Xath5 BAC 40 129 33 26% 14 5 0 14 42
Xath5 BAC 80 151 22 15% 8 3 1 10 36
RaxGFPfusion BAC 20 113 55 49% 18 2 7 28 33
RaxGFPfusion BAC 40 149 79 53% 31 11 5 32 39
RaxGFPfusion BAC 80 154 17 11% 3 0 2 12 18
IS Pax6GFP 20 138 62 45% 0 0 54 8 0
IS Pax6GFP 40 100 19 19% 0 0 18 1 0
Pax6-GFP pTARBAC2.1 40 142 73 51% 2 6 14 51 3
Pax6-GFP pTARBAC2.1 80 150 39 26% 0 1 9 29 0
a

Only embryos with normal appearance were scored.

b

Indicates the percentage of normal embryos scored from the injected count.

c

Indicates embryos expressing in a subset of correct tissues for a given reporter. IS Pax6GFP-injected and Pax6-GFP pTARBAC2.1-injected embryos were scored as correct expressors if GFP expression recapitulated either endogenous Pax6 expression or previously reported integrated transgene expression (Hirsch et al., 2002; Ogino et al., 2006).